Axa S.A. Intra Cellular Therapies, Inc. Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$12.31 - $33.12 $2.49 Million - $6.69 Million	-202,011 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$7.47 - $14.03 $519,165 - $975,085	69,500 Added 52.45%	202,011 $1.51 Million
Q2 2019 Aug 13, 2019	BUY	$10.65 - $14.29 $9,585 - $12,861	900 Added 0.68%	132,511 $1.72 Million
Q1 2019 May 14, 2019	BUY	$10.9 - $14.09 $1.43 Million - $1.85 Million	131,611 New	131,611 $1.6 Million

378

84.1M

319K

143K

Ticker ITCI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 94,401,696
Market Cap $7.86B
Description
Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.